Friday, April 28, 2017 9:57:39 AM
It's important to remember the application of R18! We're talking
about individuals, who face a very high probability of death (after
exposure to radiation), and subjective reactions, such as blurred
vision will not be decisive.
I'm sure they did do a massive number of tests to see if any
significant biological indicators were negatively effected,
and they say, no, things are looking good.
My feeling is that due to the issues with N.Korea, the threat
of terrorists with dirty bombs, and the possibility of industrial
accidents, it would be the height of irresponsibility NOT to
have a good supply of R18 stashed away and ready to be
used. Waiting till 2019 to start building up a supply of R-18
and at the same time giving Pluristam the means to scale
up their production capabilities cannot wait (at least if I
was in charge!).
Safety studies can continue even as the responsible agencies
acquire a supply of the stuff, just in case...!
That would be my argument for pps relevant news much earlier
than 2019.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM